Gujarat: BN Holdings Ltd, a parent company of BN group, today announced its entry into the specialty and oleo chemical sector. The BN Holdings Limited, through its subsidiary Epitome Industries India Limited, is establishing a state-of-the-art manufacturing facility near Kandla port, Gujarat. Once operational, it will be the largest oleo chemical manufacturing unit in India, strengthening the nation’s industrial base and advancing the Make in India vision with green alignment.
With this expansion, BN Group aims to nearly thrice its consolidated turnover to ₹25,000 crore within next two years, up from the current ₹9,000 crore. The new facility will manufacture a range of oleo and specialty chemicals used in personal care, pharmaceuticals, agrochemicals, food, and industrial applications. The plant’s output will serve both domestic markets and international customers, supporting India’s ambitions of becoming a global hub for sustainable chemical manufacturing.
The project represents one of the largest planned investments in India’s specialty chemical sector, with an estimated investment of 1200 crore. It is expected to generate 2000 direct and indirect jobs for Gujarat, contributing significantly to local economic development.
Anubhav Agarwal, Founder of BN Group, said, “This marks a defining chapter for us. With Epitome Industries leading this sunrise sector, we are building more than just a plant, we are shaping India’s largest oleo chemical hub. This facility will stand for scale, sustainability, and innovation, creating opportunities for Gujarat and setting new industry benchmarks. Our goal is long-term value creation for stakeholders while driving industrial growth and future-ready manufacturing for the nation.”
India’s oleochemicals market is projected to reach US$ 2.77 billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030, driven by the global shift toward bio-based and sustainable chemical alternatives. By establishing this mega facility, BN Group is poised to capture a substantial share of this growth while expanding both domestic markets and international markets. This expansion reflects BN Group’s strategy of building high-impact businesses across sectors, following the success of Nutrica in the health and wellness space.